- Home
- ROIV vs IP Comparison
ROIV vs IP Comparison
Compare ROIV & IP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ROIV | IP |
|---|---|---|
| Founded | 2014 | 1898 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Paper |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.7B | 21.5B |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | ROIV | IP |
|---|---|---|
| Price | $28.58 | $39.46 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 9 |
| Target Price | $27.56 | ★ $48.50 |
| AVG Volume (30 Days) | ★ 6.3M | 5.9M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 4.48% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $29,053,000.00 | N/A |
| Revenue This Year | N/A | $7.71 |
| Revenue Next Year | $385.85 | $3.88 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $8.73 | $35.56 |
| 52 Week High | $30.03 | $56.64 |
Technical Indicators
Market Signals| Indicator | ROIV | IP |
|---|---|---|
| Relative Strength Index (RSI) | 63.29 | 31.26 |
| Support Level | $20.46 | $36.95 |
| Resistance Level | N/A | $39.52 |
| Average True Range (ATR) | 0.95 | 1.61 |
| MACD | -0.00 | -0.83 |
| Stochastic Oscillator | 66.80 | 2.17 |
Price Performance
Historical ComparisonAbout ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
About IP International Paper Company
International Paper manufactures packaging products and cellulose fibers. It accounts for roughly one-third of the North American corrugated packaging market. The company also has a substantial presence in Europe following its acquisition of DS Smith. International Paper serves a variety of end markets, including industrial, consumer products, and manufacturing.